Modulation of the MHC class I and II molecules by bacterial products on intestinal epithelial cells.
Schiffrin
E J
EJ
Nestlé Research Centre, Vers-Chez-les-Blanc, Lausanne, Switzerland.
Borel
Y
Y
Donnet-Hughes
A
A
D000230:Adenocarcinoma / Q000235:genetics / Q000276:immunology / Q000473:pathology; D001419:Bacteria / Q000378:metabolism; D002772:Cholera Toxin / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000235:genetics / Q000276:immunology / Q000473:pathology; D004768:Enterotoxins / Q000494:pharmacology*; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D005805:Genes, MHC Class I / Q000187:drug effects; D005802:Genes, MHC Class II / Q000187:drug effects; D006680:HLA Antigens / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D004768:Enterotoxins; D006680:HLA Antigens; C031818:enterotoxin B, staphylococcal; D009240:N-Formylmethionine Leucyl-Phenylalanine; D002772:Cholera Toxin